Molteni

Showing 1 posts of 1 posts found.

Titan Therapeutics’ opioid dependence implant Sixmo approved in Europe

June 27, 2019
Sales and Marketing Molteni, Sixmo, Titan Therapeutics, pharma

The European Commission has awarded marketing approval to Sixmo, a subdermal buprenorphine implant from Titan Therapeutics and Molteni, in all …

The Gateway to Local Adoption Series

Latest content